Related Experiment Videos

Sudden cardiac death risk stratification and assessment: primary prevention based on ejection fraction criteria

Samir Saba1

  • 1Cardiovascular Electrophysiology Section, University of Pittsburgh Medical Center, 200 Lothrop Street, PUH B535, Pittsburgh, PA 15213, USA. sabas@upmc.edu

Heart Failure Clinics
|March 29, 2011
PubMed

Insights

Sudden cardiac death (SCD) is a leading cause of mortality. While left ventricular ejection fraction (EF) aids risk assessment, this review highlights its limitations in predicting mortality for primary SCD prevention.

Area of Science:

  • Cardiology
  • Clinical Trials
  • Preventive Medicine

Background:

  • Sudden cardiac death (SCD) represents a significant cause of mortality in the United States.
  • Left ventricular ejection fraction (EF) is currently the primary clinical marker for assessing SCD risk in primary prevention strategies.
  • Identifying patients at risk is crucial for implementing effective preventive measures.

Purpose of the Study:

  • To review data from major randomized clinical trials concerning implantable cardioverter-defibrillator (ICD) implantation for primary SCD prevention in patients with low EF.
  • To critically evaluate the efficacy of EF as a sole clinical marker for stratifying mortality risk in this patient population.

Main Methods:

  • Systematic review of major randomized clinical trials.
  • Analysis of data focusing on patients with low left ventricular ejection fraction (EF).
  • Evaluation of implantable cardioverter-defibrillator (ICD) implantation outcomes for primary prevention of sudden cardiac death (SCD).

Main Results:

  • Major clinical trials have utilized low EF as a key criterion for patient selection in primary SCD prevention.
  • Evidence suggests that EF, while useful, has limitations in accurately stratifying long-term mortality risk.
  • The effectiveness of ICDs in primary prevention is strongly linked to EF, but other factors also influence outcomes.

Conclusions:

  • Left ventricular ejection fraction (EF) remains a cornerstone in identifying candidates for primary prevention of sudden cardiac death (SCD) with implantable cardioverter-defibrillators (ICDs).
  • However, the reliance on EF alone for mortality risk stratification has demonstrable shortcomings.
  • Further research is needed to refine risk assessment models beyond EF for optimizing primary SCD prevention strategies.

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...